Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-01-08 @ 12:22 PM
Study NCT ID:
NCT00483860
Status:
COMPLETED
Last Update Posted:
2017-11-13
First Post:
2007-06-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06-20
Start Date Type:
ACTUAL
Primary Completion Date:
2012-02-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02-06
Completion Date Type:
ACTUAL
First Submit Date:
2007-06-05
First Submit QC Date:
None
Study First Post Date:
2007-06-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-11-08
Last Update Post Date:
2017-11-13
Last Update Post Date Type:
ACTUAL